Russia’s Cancer Vaccine Threatens $1.6T Pharma Industry
JUST IN: Russia unveils a free cancer vaccine that could disrupt the $1.6 trillion U.S. and European pharmaceutical markets. Analysts predict Moscow could earn $1 trillion within two years by selling to allies, reshaping global healthcare and biotech dynamics.





